Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04094844 · ClinicalTrials.gov registry record · NA
Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 372
- Enrollment target
NCT04094844 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 372 participants.
The verdict
NCT04094844, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 372 participants
- Enrollment target
Study Summary
The purpose of this research study is to measure the effects of using a mobile phone app (Roadmap 2.0) on the health-related quality of life of caregivers and patients undergoing allogeneic/autologous hematopoietic cell transplantation (HCT).
Interventions
- OTHER Survey administration
- BEHAVIORAL Roadmap 2.0 information system
- OTHER Wearable activity sensor
- BEHAVIORAL Roadmap 2.0 information system with Positive Activities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 372 participants |
| Start Date | 2020-09-08 |
| Est. Completion | 2024-08-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04094844
The ClinicalTrials.gov registry entry for NCT04094844 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 372 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Survey administration is the first listed.
NCT04094844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04094844 about?
NCT04094844 is a clinical study titled "Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation". The purpose of this research study is to measure the effects of using a mobile phone app (Roadmap 2.0) on the health-related quality of life of caregivers and patients undergoing allogeneic/autologous hematopoietic cell transplantation (HCT).
What is the current status of trial NCT04094844?
This trial is currently completed. It is a NA study. The enrollment target is 372 participants. The study started on 2020-09-08. Estimated completion is 2024-08-11.
What interventions are being tested in trial NCT04094844?
The interventions under investigation include: Survey administration (OTHER), Roadmap 2.0 information system (BEHAVIORAL), Wearable activity sensor (OTHER), Roadmap 2.0 information system with Positive Activities (BEHAVIORAL).
Who is sponsoring clinical trial NCT04094844?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.